ClinicalTrials.gov
ClinicalTrials.gov Menu

Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01883089
Recruitment Status : Completed
First Posted : June 21, 2013
Last Update Posted : May 17, 2017
Sponsor:
Information provided by (Responsible Party):
Robert Schlauch, University of South Florida

Brief Summary:
The current study combines both clinical trial and daily process methodology to examine the dynamic longitudinal relationships between daily approach and avoidance inclinations (i.e., craving) and drinking behaviors in those diagnosed with an Alcohol Use Disorder (AUD) prior to, during, and after receiving a brief alcohol intervention. It is hypothesized that daily avoidance inclinations will significantly moderate the effect of daily approach inclinations on drinking behaviors, and that significant increases in avoidance inclinations will be observed prior to treatment entry, followed by significant decreases in approach inclinations during treatment.

Condition or disease Intervention/treatment Phase
Alcohol Dependence Behavioral: Motivational Enhancement Therapy Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Ambivalence Model of Craving: Re-examining the Drinking-craving Relationship
Study Start Date : January 2015
Actual Primary Completion Date : May 2017
Actual Study Completion Date : May 2017

Arm Intervention/treatment
Other
Participants will be recruited to complete a 90 day daily monitoring study during which time will be invited to participate in a 4 week brief alcohol intervention during days 31-60 (i.e., second month).
Behavioral: Motivational Enhancement Therapy



Primary Outcome Measures :
  1. Drinks per day [ Time Frame: participants will be followed for the duration of the study, an expected average of 90 days ]
    Drinks consumed per day will be monitored daily over 90 days using interactive voice response systems (i.e., telephone call in).


Secondary Outcome Measures :
  1. Approach inclinations [ Time Frame: participants will be followed for the duration of the study, an expected average of 90 days ]
    Approach inclinations (desires to use alcohol) will be collected daily over 90 days using interactive voice response systems (i.e., telephone call in).

  2. Avoidance inclinations [ Time Frame: participants will be followed for the duration of the study, an expected average of 90 days ]
    Avoidance inclinations (desires to not use alcohol) will be collected daily over 90 days using interactive voice response systems (i.e., telephone call in).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • current diagnosis of alcohol dependence
  • live within commuting distance of the program site,
  • regular access to a phone to call into an IVR system and
  • provide informed consent

Exclusion Criteria:

  • acute psychosis or severe cognitive impairment
  • current or previous treatment for an alcohol use disorder within the past 6 months,
  • taking medications that may modify alcohol use,
  • current drug use diagnosis other than nicotine or marijuana abuse,
  • lack of sufficient familiarity with the English language to comprehend the recruitment and consent procedures, and
  • legally mandated to attend treatment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01883089


Locations
United States, Florida
University of South Florida
Tampa, Florida, United States, 33620
Sponsors and Collaborators
University of South Florida
Investigators
Principal Investigator: Robert C Schlauch, Phd University of South Florida

Responsible Party: Robert Schlauch, Assistant Professor, University of South Florida
ClinicalTrials.gov Identifier: NCT01883089     History of Changes
Other Study ID Numbers: Craving and Drinking
First Posted: June 21, 2013    Key Record Dates
Last Update Posted: May 17, 2017
Last Verified: May 2017

Additional relevant MeSH terms:
Alcoholism
Alcohol-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders